ATRASENTAN
UNII V6D7VK2215

Substance Identification & Data

This profile provides standardized clinical and technical data for Atrasentan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) V6D7VK2215.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 173937-91-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

V6D7VK2215

CAS Registry Number

173937-91-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ATRASENTAN

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

V6D7VK2215

The specific atomic composition represented as a molecular structure string.

InChIKey

C29H38N2O6

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

MOTJMGVDPWRKOC-QPVYNBJUSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C61606

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

159594

Unique identification number in the NCBI database of chemical substances.

INN ID

7970

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@H]1([C@H](CN([C@H]1c2ccc(cc2)OC)CC(N(CCCC)CCCC)=O)c3cc4OCOc4cc3)C(=O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Atrasentan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.